Literature DB >> 1329592

Enhanced production of oxygen radicals in nocturnal asthma.

N N Jarjour1, W W Busse, W J Calhoun.   

Abstract

Although the mechanisms of nocturnal worsening of pulmonary function in asthmatics have not been entirely established, airway inflammation is felt to be a major factor in disease severity. Consequently, to determine whether changes in bronchoalveolar lavage (BAL) fluid cellular components and their functions are related to nocturnal airway obstruction, we performed BAL at 4:00 A.M. and at 4:00 P.M. in asthma subjects with (n = 5) and without (n = 10) nocturnal asthma. No significant changes were observed from 4:00 P.M. to 4:00 A.M. in the concentration of total cells or the percentage or concentration of eosinophils or neutrophils in BAL fluid from subjects with or without nocturnal asthma. However, superoxide anion generation by air-space cells from subjects with nocturnal asthma was significantly greater at 4:00 A.M. than at 4:00 P.M. (6.9 +/- 1.7 versus 1.8 +/- 0.5 nmol/500K cells/h, p less than 0.05). Moreover, superoxide production at 4:00 A.M. was greater in subjects with than in those without nocturnal asthma (6.9 +/- 1.7 versus 2.2 +/- 0.6, p less than 0.02). Furthermore, in our group of asthmatics, the change in generation of superoxide anion from 4:00 P.M. to 4:00 A.M. was significantly correlated with the change in FEV1 (r = -0.71, p less than 0.01). We conclude that the development of nocturnal airway obstruction in asthma is associated with enhanced production of oxygen radicals by air-space cells. Because oxygen radicals can cause airway injury and thus enhance bronchial obstruction, it is possible that the release of these reactive compounds is causally associated with nocturnal asthma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329592     DOI: 10.1164/ajrccm/146.4.905

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

Review 1.  Oxidant stress in asthma.

Authors:  R Dworski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Lung imaging in asthmatic patients: the picture is clearer.

Authors:  Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

3.  Airway smooth muscle relaxation is impaired in mice lacking the p47phox subunit of NAD(P)H oxidase.

Authors:  Pasquale Chitano; Lu Wang; Stanley N Mason; Richard L Auten; Erin N Potts; William M Foster; Anne Sturrock; Thomas P Kennedy; John R Hoidal; Thomas M Murphy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

Review 4.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

5.  Tissue transglutaminase can be involved in airway inflammation of toluene diisocyanate-induced occupational asthma.

Authors:  Gyu-Young Hur; Sung-Ho Kim; Sang Myun Park; Young-Min Ye; Cheol-Woo Kim; An-Soo Jang; Choon-Sik Park; Chein Soo Hong; Hae-Sim Park
Journal:  J Clin Immunol       Date:  2009-06-27       Impact factor: 8.317

6.  Coenzyme Q in asthma.

Authors:  Suzy A A Comhair; Deepa Grandon; Anam Khan; Renliang Zhang; Stanley L Hazen; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

7.  Expression and translocation of Rac2 in eosinophils during superoxide generation.

Authors:  P Lacy; S Mahmudi-Azer; B Bablitz; M Gilchrist; P Fitzharris; D Cheng; S F Man; G M Bokoch; R Moqbel
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

Review 8.  New Insights in Oxidant Biology in Asthma.

Authors:  Serpil C Erzurum
Journal:  Ann Am Thorac Soc       Date:  2016-03

9.  Nocturnal asthma.

Authors:  N J Douglas
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

10.  Role of inflammation in nocturnal asthma.

Authors:  T W Mackay; W A Wallace; S E Howie; P H Brown; A P Greening; M K Church; N J Douglas
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.